CD44 and breast carcinoma: Consistent with this, Asiedu et al. demonstrated, using mouse mammary carcinoma cells (an epithelial tumor cell line), that exposure to TGF-β/TNF-α promoted a mesenchymal phenotype and increased EMT signature as well as enrichment of CD44+/CD24− CSCs and mammosphere formation.